IFN-α stimulates proliferation and cytokine secretion of CD40- stimulated B cell chronic lymphocytic leukemia cells in vitro

Journal of Interferon and Cytokine Research

Volumn 19, Issue 4, 1999, Pages 335-343

  Brass, Ute ^b   Tretter, Theresa ^b   Schneller, Folker ^b   Schuler, Martin ^b   Huber, Christoph ^b   Peschel, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CROSS LINKING; DRUG EFFECT; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR CLONING; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; CYTOKINES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INTERFERON-ALPHA; LEUKEMIA, B-CELL, CHRONIC; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED;

EID: 0032899065     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314036     Document Type: Article

References (49)

1. KARRY, S., MERLE-BERAL, H., VAZQUEZ, A., GERARD, A., DEBRE, P., and GALANAUD, P. (1987). Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal. Blood 70, 1105-1110.
2. FLUCKIGER, A.C., ROSSI, J.F., BUSSEL, A., BRYON, P., BANCHEREAU, J., and DEFRANCE, T. (1992). Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 80, 3173-3181.
3. LANKESTER, A.C., VAN SCHIJNDEL, G.M., VAN DER SCHOOT, C.E., VAN OERS, M.H., VAN NOESEL, C.J., and VAN LIER, R.A. (1995). Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood 86, 1090-1071.
4. BANCHEREAU, J., BAZAN, F., BLANCHARD, D., BRIÈRE, F., GALIZZI, J.P., VAN KOOTEN, C., LIU, Y.J., ROUSSET, F., and SAELAND, S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
5. FLUCKIGER, A.C., GARRONE, P., DURAND, I., GALIZZI, J.P., and BANCHEREAU, J. (1993). Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J. Exp. Med. 178, 1473-1481.
6. MALISAN, F., FLUCKIGER, A.C., HO, S., GURET, C., BANCHEREAU, J., and MARTTNEZ VALDEZ, H. (1996). Bchronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. Blood 87, 717-724.
7. PLANKEN, E.V., DIJKSTRA, N.H., WILLEMZE, R., and KLUIN NELEMANS, J.C. (1996). Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the "CD40 system." Leukemia 10, 488-493.
8. JACOB, A., POUND, J.D., CHALLA, A., and GORDON, J. (1998). Release of clonal block in B cell chronic lymphocytic leukaemia by engagement of co-operative epitopes on CD40. Leuk. Res. 22, 379-382.
9. WANG, D., FREEMAN, G.J., LEVINE, H., RITZ, J., and ROBERTSON, M.J. (1997). Role of CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br. J. Haematol. 97, 409-417.
10. ROMANO, M.F., LAMBERTI, A., TASSONE, P., ALFINITO, F., CONSTANTINI, S., CHIURAZZI, F., DEFRANCE, T., BONELLI, P., TUCCILLO, F., TURCO, M.C., and VENUTA, S. (1998). Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 92, 990-995.
11. SCHATTNER, E.J., MASCARENHAS, J., REYFMAN, I., KOSHY, M., WOO, C., FRIEDMAN, S.M., and CROW, M.K. (1998). Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 91, 2689-2697.
12. TRENTIN, L., ZAMBELLO, R., SANCETTA, R., FACCO, M., CERUTTI, A., PERIN, A., SIVIERO, M., BASSO, U., BORTOLIN, M., ADAMI, F., AGOSTINI, C., and SEMENZATO, G. (1997). B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res. 57, 4940-4947.
13. YOUNES, A., SNELL, V., CONSOLI, U., CLODI, K., ZHAO, S. PALMER, J.L., THOMAS, E.K., ARMITAGE, R.J., and ANDREEFF, M. (1998). Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br. J. Haematol. 100, 135-141.
14. FOA, R., MASSAIA, M., CARDONA, S., TOS, A.C., BIANCHI, A., ATTISANO, C., GUARINI, A., DI CELLE, P.F., and FIERRO, M.T. (1990). Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood 76, 393-400.
15. TRENTIN, L., ZAMELLO, R., AGOSTINI, C., SIVIERO, F., ADAMI, F., MARCOLONGO, R., RAIMONDI, R., CHISESI, T., PIZZOLO, G., and SEMENZATO, G. (1993). Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 81, 752-758.
16. BOUSSIOTIS, V.A., NADLER, L.M., STROMINGER, J.L., and GOLDFELD, A.E. (1994). Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc. Natl. Acad. Sci. USA 91, 7007-7011.
17. DI CELLE, P.F., CARBONE, A., MARCHIS, D., ZHOU, D., SOZZANI, S., ZUPO, S., PINI, M., MANTOVANI, A., and FOA, R. (1994). Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood 84, 220-228.
18. RAMBALDI, A., BETTONI, S., ROSSI, V., TINI, M.L., GIUDICI, G., RIZZO, V., BASSAN, R., MANTOVANI, A., BARBUI, T., and BIONDI, A. (1993). Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia. Br. J. Haematol. 83, 204-211.
19. TRENTIN, L., ZAMBELLO, R., AGOSTINI, C. ENTHAMMER, C., CERUTTI, A., ADAMI, F., ZAMBONI, S., and SEMENZATO, G. (1994). Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood 84, 4249-4256.
20. FOURNIER, S., DELESPESSE, G., RUBIO, M., BIRON, G., and SARFATI, M. (1992). CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J. Clin. Invest. 89, 1312-1321.
21. SOLAL-CELIGNY, P., LEPAGE, E., BROUSSE, N., REYES, F., HAIOUN, C., LEPORRIER, M., PEUCHMAUR, M., BOSLY, A., PARLIER, Y., BRICE, P., COIFFIER, B., and GISSELBRECHT, C. (1993). Recombinant interferon alpha-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N. Engl. J. Med. 329, 1608-1614.
22. SMALLEY, R.V., ANDERSEN, J.W., HAWKINS, M.J., BHIDE, V., O'CONNELL, M.J., OKEN, M.M., and BORDEN, E.C. (1992). Interferon alpha combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. N. Engl. J. Med. 327, 1336.
23. HIDDEMANN, W., UNTERHALT, M., KOCH, P., NAHLER, M., and HERRMANN, R. (1994). New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only - a preliminary update of the German Low-Grade Lymphoma Study Group. Semin. Hematol. 31 (Suppl. 3), 32-35.
24. McSWEENEY, E.N., GILES, F.J., WORMAN, C.P., JEWEL, A.P., TSAKONA, C.P., HOFFBRAND, A.V., MEHTA, A.B., NEWLAND, A.C., CAWLEY, J.C., GALVANI, D., et al. (1993). Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia. Br. J. Haematol. 85, 77-83.
25. FERRARA, F., RAMETTA, V., MELE, G., ANTINOLFI, I., METTIVIER, V., and CIMINO, R. (1992). Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy. Am. J. Hematol. 41, 45-49.
26. ZIEGLER-HEITBROCK, H.W., SCHLAG, R., FLIEGER, D., and THIEL, E. (1989). Favorable response of early stage B CLL patients to treatment with IFN-alpha 2. Blood 73, 1426-1430.
27. FOON, K.A., BOTTINO, G.C., ABRAMS, P.C., FER, M.F., LONGO, D.L., SCHOENBERGER, C.S., and OLDHAM, R.K. (1985). Phase II trial of recombinant leucocyte A interferon in patients with advanced chronic lymphoeytic leukemia. Am. J. Med. 78, 216-220.
28. O'BRIEN, S., KANTARJIAN, H., BERAN, M., ROBERTSON, L.E., KOLLER, C., LERNER, S., and KEATING, M.J. (1995). Interferon maintenance therapy for patients with chronic lymphoeytic leukemia in remission after fludarabine therapy. Blood 86, 1298-1300.
29. VEDANTHAM, S., GAMLIEL, H., and COLOMB, H.M. (1992). Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy. Cancer Res. 52, 1056-1066.
30. HESLOP, H.E., BIANCHI, A.C., CORDINGLEY, F.T., TURNER, M., CHANDIMA, W., DE MEL, C.P., HOFFBRAND, A.V., and BRENNER, M.K. (1990). Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders. J. Exp. Med. 172, 1729-1734.
31. OSTLUND, L., GRANDER, D., JULIUSSON, G., ROBERT, K.H., LUNDGREN, E., and EINHORN, S. (1989). Alpha-interferon receptors in malignant B-cells from patients with chronic lymphoeytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation. Cancer Res. 49, 3425-3430.
32. OSTLUND, L., BIBERFELD, P., ROBERT, K.H., CHRISTENSSON, B., and EINHORN, S. (1989). Induction of proliferation and blast transformation by interferon in human malignant and nonmalignant lymph node B cells. Blood 73, 2171-2181.
33. KARRAY, S., DELFRAISSY, J.F., MERLE-BERAL, H., WALLON, C., DEBRE, P., and GALANAUD, P. (1988). Positive effects of interferon-alpha on B cell-type chronic lymphoeytic leukemia proliferative response. J. Immunol. 140, 774-778.
34. PANAYIOTIDIS, P., GANESHAGURU, K., JABBAR, S.A., and HOFFBRAND, A.V. (1994). Alpha-interferon (alpha-IFN) protects B-chronic lymphoeytic leukaemia cells from apoptotic cell death in vitro. Br. J. Haematol. 86, 169-173.
35. BUSCHLE, M., CAMPANA, D., CARDING, S.R., RICHARD, C., HOFFBRAND, A.V., and BRENNER, M.K. (1993). Interferon gamma inhibits apoptotic cell death in B cell chronic lymphoeytic leukemia. J. Exp. Med. 177, 213-218.
36. DANESCU, M., RUBIO-TRUJILLO, M., BIRON, G., BRON, D., DELESPESSE, G., and SARFATI, M. (1992). Interleukin 4 protects chronic lymphoeytic leukemia B cells from death by apoptosis and upregulates bcl-2 expression. J. Exp. Med. 176, 1319-1326.
37. CARLSSON, M., SUNDSTROM, C., BENGTSSON, M., TOTTERMAN, T.H., ROSEN, A., and NILSSON, K. (1989). Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphoeytic leukemia cells depending on the co-stimulatory activation and progression signals. Eur. J. Haematol. 19, 913-921.
38. OSTLUND, L., EINHORN, S., ROBERT, K.H., JULIUSSON, G., and BIBERFELD, P. (1986). Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro. Blood 67, 152-159.
39. FLUCKIGER, A.C., DURAND, I., and BANCHEREAU, J. (1994). Interleukin 10 induces apoptotic cell death of B-chronic lymphoeytic leukemia cells. J. Exp. Med. 179, 91-99.
40. KARRAY, S., DE FRANCE, T., MERLE-BÉRAL, H., BANCHEREAU, J., DEBRE, P., and GALANAUD, P. (1988). Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells. J. Exp. Med. 168, 85-94.
41. BIONDI, A., ROSSI, V., BASSAN, R., BARBUI, T., BETTONI, S., SIRONI, M., MANTOVANI, A., and RAMBALDI, A. (1989). Constitutive expression of the interleukin-6 gene in chronic lymphoeytic leukemia. Blood 73, 1279-1284.
42. BURDIN, N., VAN KOOTEN, C., GALIBERT, L., ABRAMS, J.S., WIJDENES, J., BANCHEREAU, J., and ROUSSET, F. (1995). Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154, 2533-2544.
43. RIECKMANN, P., D'ALESSANDRO, F., NORDAN, R.P., FAUCI, A.S., and KEHRL, J.H. (1991). IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. J. Immunol. 146, 3462-3468.
44. LARSSON, L.G., CARLSSON, M., SCHENA, M., LANTZ, M., CALIGARIS-CAPPIO, F., and NISSON, K. (1993). Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells. Leukemia 7, 226-234.
45. AMAN, M.J., KELLER, U., DERIGS, G., MOHAMADZADEH, M., HUBER, C., and PESCHEL, C. (1994). Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood 83, 4142-4150.
46. OLIVEIRA, I.C, SCIAVOLINO, P.J., LEE, T.H., and VILCEK, J. (1992). Downregulation of interleukin 8 gene expression in human fibroblasts: mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. USA 89, 9049-9053.
47. AMAN, M.J., RUDOLF, G., GOLDSCHMITT, J., AULITZKY, W.E., LAM, C., HUBER, C., and PESCHEL, C. (1993). Type I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 82, 2371-2378.
48. + T cells and monocytes. Blood 87, 4731-4736.
49. TILG, H., MIER, J.W., VOGEL, W., AULITZKY, W.E., WIEDERMANN, C.J., VANNIER, E., HUBER, C., and DINARELLO, C.A. (1993). Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol. 150, 4687-4692.